Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: A novel mechanism of endothelial cell anergy

Neoplasia

Volumn 11, Issue 10, 2009, Pages 1054-1063

  Blaheta, Roman A ^a   Powerski, Maciej ^a   Hudak, Lukasz ^a   Juengel, Eva ^a   Jonas, Dietger ^a   Von Knethen, Andreas ^b   Doerr, Hans Willhelm ^a   Cinatl Jr , Jindrich ^c  

^a GOETHE UNIVERSITY   (Germany)

^b Institut für Pathobiochemie   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V4 ANTIGEN; CD44V5 ANTIGEN; CD44V7 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL INTERACTION; CLONAL ANERGY; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUTROPHIL CHEMOTAXIS; PERIPHERAL LYMPHOCYTE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 70149109810     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09762     Document Type: Article

References (27)

1. Igney FH and Krammer PH (2002). Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol 71, 907-920.
2. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, and Musiani P (2001). The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97, 339-345. (Pubitemid 32060315)
3. Simons MP, O'Donnell MA, and Griffith TS (2008). Role of neutrophils in BCG immunotherapy for bladder cancer. Urol Oncol 26, 341-345. (Pubitemid 351885380)
4. Jackaman C, Lew AM, Zhan Y, Allan JE, Koloska B, Graham PT, Robinson BW, and Nelson DJ (2008). Deliberately provoking local inflammation drives tumors to become their own protective vaccine site. Int Immunol 20, 1467-1479.
5. Halapi E (1998). Oligoclonal T cells in human cancer. Med Oncol 15, 203-211.
6. Ribas A, Butterfield LH, Glaspy JA, and Economou JS (2003). Current developments in cancer vaccines and cellular immunotherapy. J ClinOncol 21, 2415-2432. (Pubitemid 46621880)
7. Rosenberg SA (2004). Shedding light on immunotherapy for cancer. N Engl J Med 350, 1461-1463.
8. Wu NZ, Klitzman B,Dodge R, and DewhirstMW(1992).Diminished leukocyteendothelium interaction in tumor microvessels. Cancer Res 52, 4265-4268.
9. Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Boumater Steege JC, Wagstaff J, and Griffioen AW (2003). Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 63, 2322-2329. (Pubitemid 36538644)
10. Maksan SM, Araib PM, Ryschich E, Gebhard MM, and Schmidt J (2004). Immune escape mechanism: defective resting and stimulated leukocyte-endothelium interaction in hepatocellular carcinoma of the rat. Dig Dis Sci 49, 859-865. (Pubitemid 38870215)
11. Cinatl J Jr, Vogel JU, Cinatl J, Weber B, Rabenau H, Novak M, Kornhuber B, and Doerr HW (1996). Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int J Cancer 65, 90-96. (Pubitemid 26027541)
12. Chen RL, Reynolds CP, and Seeger RC (2000). Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating. Cancer Immunol Immunother 48, 603-612.
13. David K, Ollert MW, Juhl H, Vollmert C, Erttmann R, Vogel CW, and Bredehorst R (1996). Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans. Nat Med 2, 686-689. (Pubitemid 26191957)
14. Takamizawa S, Okamoto S,Wen J, BishopW, Kimura K, and Sandler A (2000). Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing. J Pediatr Surg 35, 375-379. (Pubitemid 30082604)
15. Chen YL, Chen SH, Wang JY, and Yang BC (2003). Fas ligand on tumor cells mediates inactivation of neutrophils. J Immunol 171, 1183-1191.
16. Jackaman C, Lew AM, Zhan Y, Allan JE, Koloska B, Graham PT, Robinson BW, and Nelson DJ (2008). Deliberately provoking local inflammation drives tumors to become their own protective vaccine site. Int Immunol 20, 1467-1479.
17. Zen K, Liu DQ, Li LM, Chen CX, Guo YL, Ha B, Chen X, Zhang CY, and Liu Y (2009). The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration. J Biol Chem 284, 3768-3776.
18. Hurley BP, Sin A, and McCormick BA (2008). Adhesion molecules involved in hepoxilin A3-mediated neutrophil transepithelial migration. Clin Exp Immunol 151, 297-305.
19. Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, Ruffell B, Johnson P, and Kubes P (2004). Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 173, 7594-7601. (Pubitemid 39628201)
20. Rouschop KM, Roelofs JJ, Claessen N, da Costa Martins P, Zwaginga JJ, Pals ST, Weening JJ, and Florquin S (2005). Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 16, 2034-2043. (Pubitemid 41716434)
21. Piali L, Fichtel A, Terpe HJ, Imhof BA, and Gisler RH (1995). Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J ExpMed 181, 811-816.
22. Hellebrekers DM, Castermans K, Viré E, Dings RP, Hoebers NT, Mayo KH, Oude EgbrinkMG,Molema G, Fuks F, van Engeland M, et al. (2006). Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 66, 10770-10777. (Pubitemid 44876972)
23. Sawada T, Kimura K, Nishihara T, Onoda N, Teraoka H, Yamashita Y, Yamada N, Yashiro M, Ohira M, and Hirakawa K (2006). TGF-β1 down-regulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer. Adv Med Sci 51, 60-65.
24. Carpenter AC and Alexander JS (2008). Endothelial PKCδ activation attenuates neutrophil transendothelial migration. Inflamm Res 57, 216-229.
25. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, and Remuzzi G (1998). Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 101, 1905-1915. (Pubitemid 28226110)
26. Takeuchi Y, Okayama N, Imaeda K, Okouchi M, Omi H, Imai S, Akao M, Takeda Y, Hukutomi T, and ItohM(2007). Effects of histamine 2 receptor antagonists on endothelial-neutrophil adhesion and surface expression of endothelial adhesion molecules induced by high glucose levels. J Diabetes Complications 21, 50-55.
27. Zittermann SI and Issekutz AC (2006). Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 168, 835-846.